valproic acid has been researched along with lurasidone hydrochloride in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (85.71) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Calabrese, F; Fumagalli, F; Guidotti, G; Luoni, A; Racagni, G; Riva, MA | 1 |
| Calabrese, JR; Cucchiaro, J; Kroger, H; Loebel, A; Sarma, K; Silva, R; Xu, J | 1 |
| Belmaker, RH | 1 |
| Alamo, C; García-García, P; López-Muñoz, F | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Citrome, L | 1 |
| Dhillon, S; Sanford, M | 1 |
| Bacci, ED; Calabrese, J; Loebel, A; Ng-Mak, D; Pikalov, A; Rajagopalan, K; Wyrwich, K | 1 |
| Chapel, S; Chiu, YY; Cucchiaro, J; Hsu, J; Loebel, A | 1 |
| Cucchiaro, J; Ketter, TA; Kroger, H; Loebel, A; Sarma, K; Silva, R | 1 |
| Kroger, H; Loebel, A; Pikalov, A; Suppes, T | 1 |
| Bacci, ED; Loebel, A; Ng-Mak, D; Pikalov, A; Rajagopalan, K; Wyrwich, K | 1 |
| Cucchiaro, J; Forester, BP; Kroger, H; Loebel, A; Pikalov, A; Sajatovic, M; Tsai, J | 1 |
| Hermann, AD; Susser, LC | 1 |
| Calabrese, JR; Cucchiaro, J; Loebel, A; Mao, Y; Pikalov, A; Streicher, C | 1 |
| Cucchiaro, J; Forester, BP; Loebel, A; Pikalov, A; Sajatovic, M; Tsai, J | 1 |
| Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
| Connor, DF; Prieto, DI; Zehgeer, AA | 1 |
| Ali, Z; El-Mallakh, RS; Tegin, C | 1 |
| Chua, CJM; Nair, SS; Teo, DCL | 1 |
| De Berardis, D; Maina, G; Martinotti, G; Ricci, V | 1 |
6 review(s) available for valproic acid and lurasidone hydrochloride
| Article | Year |
|---|---|
The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Isoindoles; Lithium; Lurasidone Hydrochloride; Thiazoles; Treatment Outcome; Valproic Acid | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Treatment of bipolar depression: making sensible decisions.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2014 |
Lurasidone: a review of its use in adult patients with bipolar I depression.
Topics: Adult; Bipolar Disorder; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Lithium Compounds; Lurasidone Hydrochloride; Psychotropic Drugs; Valproic Acid | 2015 |
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
Evaluating lurasidone as a treatment option for bipolar disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Lurasidone Hydrochloride; Randomized Controlled Trials as Topic; Recurrence; Valproic Acid | 2020 |
7 trial(s) available for valproic acid and lurasidone hydrochloride
| Article | Year |
|---|---|
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2014 |
Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Lurasidone Hydrochloride; Male; Quality of Life; Valproic Acid; Young Adult | 2016 |
Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Computer Simulation; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Middle Aged; Models, Theoretical; Placebo Effect; Psychiatric Status Rating Scales; Valproic Acid | 2016 |
Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Least-Squares Analysis; Lithium Compounds; Lurasidone Hydrochloride; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Valproic Acid; Young Adult | 2016 |
Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Health Status; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Valproic Acid | 2016 |
Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies.
Topics: Aged; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Lurasidone Hydrochloride; Male; Middle Aged; Valproic Acid | 2016 |
Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Lithium Compounds; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Time Factors; Treatment Outcome; Valproic Acid | 2017 |
8 other study(ies) available for valproic acid and lurasidone hydrochloride
| Article | Year |
|---|---|
Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.
Topics: Affect; Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Drug Therapy, Combination; Gene Expression; Hippocampus; Isoindoles; Lurasidone Hydrochloride; Male; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Thiazoles; Valproic Acid | 2013 |
Lurasidone and bipolar disorder.
Topics: Bipolar Disorder; Female; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Male; Thiazoles; Valproic Acid | 2014 |
LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Time; Treatment Outcome; Valproic Acid | 2016 |
Protection against hormone-mediated mood symptoms.
Topics: Affect; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium; Lurasidone Hydrochloride; Menstrual Cycle; Premenstrual Syndrome; Psychotic Disorders; Treatment Outcome; Valproic Acid; Young Adult | 2017 |
Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
Topics: Aged; Aged, 80 and over; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Outcome Assessment, Health Care; Valproic Acid | 2018 |
Use of Suvorexant for Sleep Regulation in an Adolescent with Early-Onset Bipolar Disorder.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Azepines; Bipolar Disorder; Humans; Lurasidone Hydrochloride; Male; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Triazoles; Valproic Acid | 2019 |
Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Compounds; Lurasidone Hydrochloride; Male; Mania; Olanzapine; Quetiapine Fumarate; Valproic Acid | 2021 |
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lurasidone Hydrochloride; Valproic Acid | 2022 |